S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
BREAKING: Tiny biotech successfully treats blindness (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
66,000% upside on tiny biotech? (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
BREAKING: Tiny biotech successfully treats blindness (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
66,000% upside on tiny biotech? (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
BREAKING: Tiny biotech successfully treats blindness (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
66,000% upside on tiny biotech? (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
BREAKING: Tiny biotech successfully treats blindness (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BREAKING: Tiny biotech successfully treats blindness (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
66,000% upside on tiny biotech? (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
NYSE:STVN

Stevanato Group (STVN) Price Target & Analyst Ratings

€28.99
-0.05 (-0.17%)
(As of 06/9/2023 08:49 PM ET)
Compare
Today's Range
€28.70
€30.00
50-Day Range
€25.15
€29.04
52-Week Range
€13.71
€30.00
Volume
205,700 shs
Average Volume
295,010 shs
Market Capitalization
$8.57 billion
P/E Ratio
50.86
Dividend Yield
N/A
Price Target
€29.60

Stevanato Group Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 4 Analyst Ratings

Consensus Analyst Price Target

N/A

TypeCurrent
6/10/22 to 6/10/23
1 Month Ago
5/11/22 to 5/11/23
3 Months Ago
3/12/22 to 3/12/23
1 Year Ago
6/10/21 to 6/10/22
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
7 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Get Stevanato Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.


STVN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STVN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Stevanato Group Stock vs. The Competition

TypeStevanato GroupMedical Companies
Consensus Rating Score
3.00
2.66
Consensus RatingBuyBuy
News Sentiment RatingPositive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/5/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$28.00 ➝ $29.00
5/5/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$27.00 ➝ $30.00
3/3/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$22.00 ➝ $27.00
3/3/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$22.00 ➝ $30.00
3/3/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$26.00 ➝ $32.00
(Data available from 6/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












STVN Price Target - Frequently Asked Questions

What is Stevanato Group's consensus rating?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Stevanato Group stock is Buy based on the current 4 buy ratings for STVNthe . Learn more on STVN's analyst rating history.

Do Wall Street analysts like Stevanato Group more than its competitors?

Analysts like Stevanato Group more than other Medical companies. The consensus rating score for Stevanato Group is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how STVN compares to other companies.

What analysts cover Stevanato Group?

Stevanato Group has been rated by UBS Group, and Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:STVN) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -